Canadian Federal officials discuss approval of Moderna COVID-19 vaccine for children under 5 – July 14, 2022

In a virtual news conference, Dr. Supriya Sharma, chief medical adviser with Health Canada, Dr. Marc Berthiaume, director of the Bureau of Medical Science at Health Canada, Dr. Howard Njoo, Canada's deputy chief public health officer, and Dr. Matthew Tunis, executive secretary to the National Advisory Committee on Immunization (NACI) discuss Health Canada’s authorization of Moderna’s COVID-19 vaccine for use in children aged six months to five years.